ArticleScientific reports2025
Investigation of Aloe vera mediated ZnO-β-CD nanocomposite for photocatalysis and antimicrobial applications.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Synthesis, characterisation and evaluation of polyethylene glycol-β-cyclodextrin-curcumin-zinc oxide nanoparticles for mosquitocidal, antibacterial and anticancer applications.Scientific reports · 2026Article
- Article
- Synthesis of the Supramolecular Structure of Vanadium Pentoxide Nanoparticles with Native and Modified β-Cyclodextrins for Antimicrobial Performance.Bioengineering (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents the green synthesis of an Aloe vera based ZnO-β-cyclodextrin (β-CD) nanocomposite for photocatalysis and antimicrobial applications. UV-Visible spectroscopy, Fourier transform infrared (FTIR), X-ray diffraction (XRD), Field emission electron microscopy (FESEM), and band gap energy measurement, were employed to investigate the optical and structural features. Due to unique bandgap (3.0 eV) and enhanced electron-hole recombination dynamics, the newly synthesized nanocomposite can not only able to demonstrate the efficient photocatalytic degradation of methylene blue (MB) dye by achieving complete discoloration at 6 pH within 160 min under visible light-a significant improvement over previously reported ZnO-based system, but furthermore, it also strongly combatted by the antibacterial activity against Gram-positive bacteria S. aureus, gram-negative bacteria E. coli, and the fungus strain A. niger. This is due to the generation of singlet oxygen (O
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.